source
- Argenx to acquire Forte Biosciences for $2.2 billion, bolstering its autoimmune drug pipelineArgenx announced it will purchase Dallas-based Forte Biosciences for $2.2 billion in cash. The transaction values Forte at $77 per share, a 41 percent premium to its closing price on Friday. The a…
- Denmark's foundation-driven biotech surge pulls Swedish startups across the Øresund, outpacing Nordic peersDenmark, and in particular its capital Copenhagen, is emerging as the leading biotech hub in the Nordic region, outpacing its neighbours in investment and talent development. Swedish biotech start…